Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis

NCT02090413 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

241

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-Remitting Multiple Sclerosis

Interventions

DRUG: dimethyl fumarate
DRUG: acetylsalicylic acid
DRUG: ASA-Placebo

Sponsor

Biogen